https://doi.org/10.1016/j.ebiom.2019.08.013
X
Xiaolin Yin
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
47
Papers
1.4K
Citations
17
h-index
21
i10-index
Xiaolin Yin is an academic researcher from Shandong University. The author has contributed to research in topics: Chronic Myeloid Leukemia Treatments & RNA Research and Splicing & MicroRNA in disease regulation. The author has an h-index of 17, co-authored 40 publications.
ORCID: 0000-0001-9311-2877Papers by this author
worksIdentification of AUNIP as a candidate diagnostic and prognostic biomarker for oral squamous cell carcinoma
2019 · EBioMedicine · 84 citations
Spatiotemporal trends of the global burden of melanoma in 204 countries and territories from 1990 to 2019: Results from the 2019 global burden of disease study
2021 · Neoplasia · 68 citations
https://doi.org/10.1016/j.neo.2021.11.013
Burden of drug use disorders in the United States from 1990 to 2021 and its projection until 2035: results from the GBD study
2024 · BMC Public Health · 60 citations
https://doi.org/10.1186/s12889-024-19142-0
Effect of IL-17 in the development of colon cancer in mice
2016 · Oncology Letters · 18 citations
https://doi.org/10.3892/ol.2016.5329
Histone chaperone ASF1A accelerates chronic myeloid leukemia blast crisis by activating Notch signaling
2022 · Cell Death and Disease · 9 citations
https://doi.org/10.1038/s41419-022-05234-5
Association between lipid ratios and sarcopenia and the mediating roles of inflammatory biomarkers in a cross-sectional study from NHANES 2011–2018
2025 · Scientific Reports · 7 citations
https://doi.org/10.1038/s41598-025-90131-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat